97
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Relationship Between Single Nucleotide Polymorphisms of SMAD3/SMAD6 and Risk of Esophageal Squamous Cell Carcinoma in Chinese Population

, , ORCID Icon, , , ORCID Icon, , , , , & show all
Pages 355-363 | Published online: 24 Aug 2020

References

  • Budi EH, Duan D, Derynck R. Transforming growth factor-β receptors and SMADs: regulatory complexity and functional versatility. Trends Cell Biol. 2017;27:658–672. doi:10.1016/j.tcb.2017.04.00528552280
  • Macias MJ, Martin-Malpartida P, Massagué J. Structural determinants of SMAD function in TGF-β signaling. Trends Biochem Sci. 2015;40:296–308. doi:10.1016/j.tibs.2015.03.01225935112
  • Miyazawa K, Miyazono K. Regulation of TGF-β family signaling by inhibitory SMADs. CSH Perspect Biol. 2017;9:a22095.
  • Chen W, Ten Dijke P. Immunoregulation by members of the TGFβ superfamily. Nat Rev Immunol. 2016;16:723–740. doi:10.1038/nri.2016.11227885276
  • Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 2019;18:197–218. doi:10.1038/s41573-018-0007-y30610226
  • Zhu H, Gu X, Xia L, et al. A novel TGFβ trap blocks chemotherapeutics-induced TGFβ1 signaling and enhances their anticancer activity in gynecologic cancers. Clin Cancer Res. 2018;24:2780–2793. doi:10.1158/1078-0432.CCR-17-311229549162
  • Fang X, Gao Y, Li Q. SMAD3 activation: a converging point of dysregulated TGF-beta superfamily signaling and genetic aberrations in granulosa cell tumor development? Biol Reprod. 2016;95:105. doi:10.1095/biolreprod.116.14341227683263
  • Matsuzaki K, Kitano C, Murata M, et al. SMAD2 and SMAD3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-β signal in later stages of human colorectal cancer. Cancer Res. 2009;69:5321–5330. doi:10.1158/0008-5472.CAN-08-420319531654
  • Bae E, Sato M, Kim RJ, et al. Definition of SMAD3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells. Cancer Res. 2014;74:6139–6149. doi:10.1158/0008-5472.CAN-14-080325205100
  • Zhao Y, Ma J, Fan Y, et al. TGF-beta transactivates EGFR and facilitates breast cancer migration and invasion through canonical SMAD3 and ERK/Sp1 signaling pathways. Mol Oncol. 2018;12:305–321. doi:10.1002/1878-0261.1216229215776
  • Han S, Kim H, Seong DH, et al. Loss of the SMAD3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene. 2004;23:1333–1341. doi:10.1038/sj.onc.120725914647420
  • Cho SY, Ha SY, Huang S, et al. The prognostic significance of SMAD3, SMAD4, SMAD3 phosphoisoform expression in esophageal squamous cell carcinoma. Med Oncol. 2014;31. doi:10.1007/s12032-014-0236-9
  • Jeon HS, Dracheva T, Yang SH, et al. SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF- homeostasis in lung cancer cells. Cancer Res. 2008;68:9686–9692. doi:10.1158/0008-5472.CAN-08-108319047146
  • Yin J, Wang L, Tang W, et al. RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population. PLoS One. 2014;9:e101705. doi:10.1371/journal.pone.010170525019155
  • Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett. 2016;370:33–38. doi:10.1016/j.canlet.2015.10.00326458996
  • Kamangar F, Chow W, Abnet C, Dawsey S. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27–57. doi:10.1016/j.gtc.2009.01.00419327566
  • Salaspuro MP. Alcohol consumption and cancer of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2003;17:679–694. doi:10.1016/S1521-6918(03)00035-012828962
  • Hu H, Xu Z, Li C, et al. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer. 2016;97:87–94. doi:10.1016/j.lungcan.2016.04.01727237033
  • Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y, Zhou LF. The miR-92b functions as a potential oncogene by targeting on SMAD3 in glioblastomas. Brain Res. 2013;1529:16–25. doi:10.1016/j.brainres.2013.07.03123892108
  • Raine EVA, Reynard LN, van de Laar IMBH, Bertoli-Avella AM, Loughlin J. Identification and analysis of a SMAD3 cis-acting eQTL operating in primary osteoarthritis and in the aneurysms and osteoarthritis syndrome. Osteoarthritis Cartil. 2014;22:698–705. doi:10.1016/j.joca.2014.02.931